Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.104ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.104ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.104NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.225ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.225ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.225ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.225NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AV.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AV.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.309ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.309ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.309ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.309NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.105ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.105ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.105ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.105NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.307ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.307ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.307ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.307NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.171ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.171ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.171ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used